N-chlorotaurine-A new safe substance for postoperative ear care

Auris Nasus Larynx

Volumn 34, Issue 1, 2007, Pages 19-22

  Neher, Andreas ^a   Gstöttner, Michaela ^a   Nagl, Markus ^b   Scholtz, Arne ^a   Gunkel, Andreas R ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

N chlorotaurine; Postoperative ear care; Tympanoplasty

Indexed keywords

CHLOROTAURINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; EAR PROTECTION; EPITHELIZATION; EXTERNAL AUDITORY CANAL; FEMALE; HUMAN; LAVAGE; MALE; POSTOPERATIVE CARE; TYMPANOPLASTY;

ADULT; ANTIVIRAL AGENTS; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TAURINE; TIME FACTORS; TYMPANOPLASTY;

EID: 33846347542     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2006.09.001     Document Type: Article

References (15)

1. Kristiansen P. The diagnosis and management of malignant (necrotizing) otitis externa. J Am Acad Nurse Pract 11 (1999) 297-300
2. Hutten R. Postoperative treatment in tympanoplasty. Acta Otorhinolaryngol Belg 31 6 (1977) 608-614
3. Wiesenthal A.A., and Garber L.Z. New method for packing the external auditory canal, middle ear space, and mastoid cavities after otologic surgery. J Otolaryngol 28 (1999) 260-265
4. Gottardi W., and Nagl M. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm (Weinheim) 335 9 (2002) 411-421
5. Weiss S.J., Lampert M.B., and Test S.T. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 222 (1983) 625-628
6. Arnitz R., Sarg B., Ott H.W., Neher A., Lindner H., and Nagl M. Protein sites of attack of N-chlorotaurine in Escherichia coli. Proteomics 6 (2006) 865-869
7. Gottardi W., and Nagl M. Chlorine covers on living bacteria: the initial step in antimicrobial action of active chlorine compounds. J Antimicrob Chemother 55 (2005) 475-482
8. Nagl M., Teuchner B., Pöttinger E., Ulmer H., and Gottardi W. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study. Ophthalmologica 214 (2000) 111-114
9. Nagl M., Nguyen V.A., Gottardi W., Ulmer H., and Höpfl R. Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study. Br J Dermatol 149 3 (2003) 590-597
10. Neher A., Nagl M., Appenroth E., Gstöttner M., Wischatta M., Reisigl F., et al. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent. Laryngoscope 114 5 (2004) 850-854
11. Neher A., Nagl M., Schrott-Fischer A., Ichiki H., Gottardi W., Gunkel A.R., et al. N-chlorotaurine, a novel endogenous antimicrobial agent: tolerability tested in a mouse model. Arch Otolaryng Head Neck Surg 127 (2001) 530-533
12. Neher A., Nagl M., Prieskorn D., Mitchell A., Brown N., Schrott-Fischer A., et al. Tolerability of N-chlorotaurine in the guinea pig middle ear-a pilot study using an improved application system. Ann Otol Rhinol Laryngol 113 1 (2004) 76-81
13. Nagl M., Pfausler B., Schmutzhard E., Fille M., and Gottardi W. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zent bl Bakteriol 288 (1998) 217-223
14. Nagl M., Hengster P., Semenitz E., and Gottardi W. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 43 (1999) 805-809
15. Barua M., Liu Y., and Quinn M.R. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 167 (2001) 2275-2281